Perez Krystle, Puia-Dumitrescu Mihai, Comstock Bryan A, Wood Thomas R, Mayock Dennis E, Heagerty Patrick J, Juul Sandra E
Division of Neonatology, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195, USA.
Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.
J Clin Med. 2023 Apr 4;12(7):2703. doi: 10.3390/jcm12072703.
Infections remain a leading cause of neonatal death, especially among the extremely preterm infants. To evaluate the incidence, pathogenesis, and in-hospital outcomes associated with sepsis among hospitalized extremely preterm infants born at 24-0/7 to 27-6/7 weeks of gestation, we designed a post hoc analysis of data collected prospectively during the Preterm Epo Neuroprotection (PENUT) Trial, NCT #01378273. We analyzed culture positive infection data, as well as type and duration of antibiotic course and described their association with in-hospital morbidities and mortality. Of 936 included infants, 229 (24%) had at least one positive blood culture during their hospitalization. Early onset sepsis (EOS, ≤3 days after birth) occurred in 6% of the infants, with Coagulase negative Staphylococci (CoNS) and Escherichia Coli the most frequent pathogens. Late onset sepsis (LOS, >day 3) occurred in 20% of the infants. Nearly all infants were treated with antibiotics for presumed sepsis at least once during their hospitalization. The risk of confirmed or presumed EOS was lower with increasing birthweight. Confirmed EOS had no significant association with in-hospital outcomes or death while LOS was associated with increased risk of necrotizing enterocolitis and death. Extremely premature infants with presumed sepsis as compared to culture positive sepsis had lower rates of morbidities. In conclusion, the use of antibiotics for presumed sepsis remains much higher than confirmed infection rates. Ongoing work exploring antibiotic stewardship and presumed, culture-negative sepsis in extremely preterm infants is needed.
感染仍然是新生儿死亡的主要原因,尤其是在极早产儿中。为了评估孕周为24 - 0/7至27 - 6/7周的住院极早产儿败血症的发病率、发病机制及住院结局,我们对早产脑保护(PENUT)试验(NCT #01378273)期间前瞻性收集的数据进行了事后分析。我们分析了培养阳性感染数据,以及抗生素疗程的类型和持续时间,并描述了它们与住院期间发病率和死亡率的关联。在纳入的936例婴儿中,229例(24%)在住院期间至少有一次血培养阳性。早发型败血症(EOS,出生后≤3天)发生在6%的婴儿中,凝固酶阴性葡萄球菌(CoNS)和大肠杆菌是最常见的病原体。晚发型败血症(LOS,>第3天)发生在20%的婴儿中。几乎所有婴儿在住院期间至少接受过一次针对疑似败血症的抗生素治疗。随着出生体重增加,确诊或疑似EOS的风险降低。确诊的EOS与住院结局或死亡无显著关联,而LOS与坏死性小肠结肠炎和死亡风险增加相关。与培养阳性败血症相比,疑似败血症的极早产儿发病率较低。总之,针对疑似败血症使用抗生素的比例仍然远高于确诊感染率。需要持续开展工作,探索极早产儿抗生素管理及疑似、培养阴性败血症的相关问题。